VA Conditioning Regimen Allo-HSCT for Elderly Higher-risk MDS

The goal of this phase 1/2 trial is to test the safety and efficacy of Venetoclax Plus Azacytidine Conditioning Regimen Allo-HSCT in treating patients with higher-risk MDS.

Lead sponsor: Navy General Hospital, Beijing•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Liren Qian, PhD

CONTACT

+861066947192 [email protected]

Related studies

RECRUITINGPhase 2

A Phase 2 Study Evaluating Olutasidenib in Combination With Hypomethylating Agents in Patients With IDH1-mutated Higher-risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Advanced Myeloproliferative Neoplasm

NCT06597734 · Chronic Myelomonocytic Leukemia, Advanced Myeloproliferative Neoplasms, and more

RECRUITINGPhase 2

A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes

NCT06196203 · Higher-risk Myelodysplastic Syndromes

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 1, 2024Terms

Trial snapshot

StatusRECRUITING

PhasePHASE1/PHASE2

Enrollment54

Start dateOct 2024

Last updatedOct 1, 2024

Condition

Higher-risk Myelodysplastic Syndromes

Locations shown

Navy General Hospital

Beijing, Beijing Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 1, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions